Ecuador approves OxfordAstraZeneca COVID vaccine for emergency use
2021-01-25 09:57
A healthcare worker receives a dose of the PfizerBioNTech coronavirus disease vaccine at the Guasmo Hospital in Guayaquil, Ecuador, on Jan , . PhotoAgencies    QUITO  Ecuadors National Agency for Health Regulation, Control, and Surveillance has approved the emergency use of the OxfordAstraZeneca vaccine against COVID, the Ministry of Public Health reported on Sunday. The OxfordAstraZeneca vaccine is the second to gain approval for use in Ecuador, after the PfizerBioNTech vaccine. Ecuador, which as of Saturday had reported , cases and , deaths from COVID, received on Jan  the first , doses of the PfizerBioNTech vaccine from a first batch of ,, which is expected to arrive progressively into February. This shipment indicated the start of the zero phase, which involves the immunization of health personnel in critical areas and elderly adults in care centers. Mass vaccinations for the rest of the population will begin in March, in accordance with international supplies.